FDA approves first synthetic surfactant to help premature babies breathe
A drug for preterm infants born with respiratory distress syndrome has been approved by U.S. regulators. The neonatology drug developed by specialty biotechnology company Discovery Labs (NASDAQ:DSCO) is designed to treat the respiratory condition in which preterm infants are born without enough pulmonary surfactant, a substance made by the lungs needed for breathing, according to […]